MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
47.64
+4.30
+9.92%
Pre Market: 50.29 +2.65 +5.56% 07:23 02/09 EST
OPEN
46.37
PREV CLOSE
43.34
HIGH
47.74
LOW
45.84
VOLUME
321.66K
TURNOVER
--
52 WEEK HIGH
91.22
52 WEEK LOW
43.08
MARKET CAP
211.48B
P/E (TTM)
13.17
1D
5D
1M
3M
1Y
5Y
1D
Novo Nordisk A/S repurchases units for DKK 222 million
Reuters · 22m ago
Novo Nordisk A/S kauft Einheiten im Wert von rund DKK 222,297,903 zurück
Reuters · 22m ago
UPDATE 1-Novo Nordisk sues Hims & Hers over patent infringement
Reuters · 25m ago
BUZZ-U.S. STOCKS ON THE MOVE-Tegna, Kroger, silver miners
Reuters · 32m ago
3 Things That Can Ease Stock Market Nerves as -2-
Barron‘s · 34m ago
3 Things That Can Ease Stock Market Nerves as Crucial Jobs Report Looms
Barron‘s · 34m ago
Novo Nordisk Files A Lawsuit Against Hims & Hers For Infringing US Patent 8,129,343 With Hims' Compounded Semaglutide Products For The US Market
Benzinga · 34m ago
*Novo Nordisk Is Also Seeking to Recover Damages
Dow Jones · 37m ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.